10x Genomics Inc. Class A Common Stock (TXG)

About TXG

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromiu…

Sector

Industrials

Industry

Biotechnology: Laboratory Analytical Instruments

Employees

1,178

Website

www.10xgenomics.com/

Fundamentals

1-day range

$60.82$65

Market cap

$5.97B

P/E (trailing)

—

P/E (forward)

302.66

EPS (trailing)

$-0.59

Dividend yield

—

Beta

2.07

Avg. volume

3.27M

Forecasts

13 analyst ratings

10x Genomics Inc. Class A Common Stock Competitors

Chosen by industry and closest market cap.

• TXG

  10x Genomics Inc. Class A Common Stock

  $61.55

  ▼ 5.10%
  Market cap $5.97BP/E —
  $11.16$66.94
• EYPT

  EyePoint Inc. Common Stock

  $4.47

  ▼ 3.46%
  Market cap $1.04BP/E —
  $3.95$19.11
• CTKB

  Cytek Biosciences Inc. Common Stock

  $4.69

  ▲ 1.41%
  Market cap $556.60MP/E —
  $3.28$6.18
• PACB

  Pacific Biosciences of California Inc. Common Stock

  $1.4

  ▼ 10.00%
  Market cap $441.05MP/E —
  $1.07$2.73
• LAB

  Standard BioTools Inc. Common Stock

  $0.64

  ▼ 1.54%
  Market cap $339.09MP/E 3.47
  $0.6251$1.72
• NAUT

  Nautilus Biotechnology Inc. Common Stock

  $0.8828

  ▼ 2.35%
  Market cap $128.53MP/E —
  $0.62$4.31
• RPID

  Rapid Micro Biosystems Inc. Class A Common Stock

  $1.56

  ▼ 3.11%
  Market cap $97.88MP/E —
  $1.52$4.94

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 10x Genomics Wins Patent Case Against Parse Biosciences As Jury Finds Willful Infringement And Awards $4.8M+ In Damages; Company To Seek Enhanced Damages, Fees And Permanent Injunction
  benzinga · 8/28/2026

Institutional Ownership

March 31, 2026

Total shares held

117.56M

Total value held

$2.45B

Institutional holders

323